Breaking News Headlines Today | Ground News

See every side of every news story

MarketWatch image

News from MarketWatch

The Ground News media bias check for MarketWatch is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

MarketWatch’s factuality rating is High. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about MarketWatch

Where is MarketWatch located?United StatesMarketWatch's Website MarketWatch's Twitter MarketWatch's Wikipedia

Media Bias Ratings

Average Bias Rating:

Center

Center

byAd Fontes Media

Center

Lean Right

byMedia Bias/Fact Check

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top MarketWatch News

HMRC: can UK tax body take money from my bank account - Direct Recovery of Debts explained as tax rule returns

Taxes · Northampton

HMRC: can UK tax body take money from my bank account - Direct Recovery of Debts explained as tax rule returns

91% Center coverage: 11 sources

HMRC’s debt crackdown has lead to worry about what really happens before the taxman can touch your money 💰See the Story

Fiserv stock craters 44%, on pace for worst day ever after company slashes guidance — Milwaukee July 2022 022 (Fiserv Forum) by Wikipedia Photo - Own work (By: Michael Barera) / CC-BY-SA-4.0

Business · United States

Fiserv stock craters 44%, on pace for worst day ever after company slashes guidance

60% Center coverage: 10 sources

Organon CEO Kevin Ali to resign after probe into contraceptive sales — REUTERS / ixx511

Business · United States

Organon CEO Kevin Ali to resign after probe into contraceptive sales

72% Center coverage: 7 sources

Organon said on Monday CEO Kevin Ali will resign from his role, after an internal investigation into sales of its Nexplanon contraceptive implant to wholesalers pointed to "improper" practices.See the Story

Breaking News Topics Related to MarketWatch